CAS No |
Product Name |
Molecular Formula |
381233-75-6
|
5-Bromo-3-iodo-2(1H)-pyridinone;5-Bromo-2-hydroxy-3-iodopyridine; 5-Bromo-3-iodo-1,2-dihydropyridin-2-one; 5-Bromo-3-iodopyridin-2(1H)-one; 5-Bromo-3-iodopyridin-2-ol
|
C5H3BrINO
|
381233-78-9
|
5-(2-Pyridyl)-1,2-dihydropyridin-2-one;(2,3'-Bipyridin)-6'(1'H)-one; 5-(Pyridin-2-yl)-2(1H)-pyridone
|
C10H8N2O
|
381233-96-1
|
2-Amino-5-bromo-3-iodopyridine;5-Bromo-3-iodopyridin-2-amine
|
C5H4BrIN2
|
381241-08-3
|
trans-2-(Fmoc-amino)cyclohexanecarboxylic acid
|
|
381241-10-7
|
N-[2-Nitro-4-(Trifluoromethyl)Phenyl]-1,3-Propanediamine
|
C10H12F3N3O2
|
381242-61-1
|
1-(4-Nitro-2-Trifluoromethylphenyl)-Piperazine
|
C11H13F3N3O2
|
381247-99-0
|
Methyl 5-Bromo-6-hydroxynicotinate
|
C7H6BrNO3
|
381248-04-0
|
2-Chloro-3-pyridylboronic acid;2-Chloropyridine-3-boronic acid
|
C5H5BClNO2
|
381248-06-2
|
3-Bromo-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one;3-Bromo-1-phenyl-5-(pyridin-2-yl)-2(1H)-pyridone
|
C16H11BrN2O
|
381666-13-3
|
2-(5-Bromo-2-Thienyl)Ethanamine Hydrobromide (1:1)
|
C6H9Br2NS
|
381670-28-6
|
N-Ethoxycarbonyl-3-Nitro-o-Toluidine
|
C10H12N2O4
|
381670-29-7
|
1-Ethyl-3-Guanidinothiourea Hydrochloride
|
C4H12ClN5S
|
381670-30-0
|
(3R)-N-Ethyl-3-pyrrolidinamine
|
C6H14N2
|
381670-31-1
|
(3S)-3-(Ethylamino)pyrrolidine;(3S)-N-Ethyl-3-pyrrolidinamine
|
C6H14N2
|
381670-32-2
|
1-Ethylprolinamide
|
C7H14N2O
|
381670-33-3
|
(R)-(+)-1-Ethyl-2-Pyrrolidinecarboxylic Acid Ethyl Ester
|
|
381679-24-9
|
2-AcetaMido-5-broMo-3-nitropyridine
|
|
381679-93-2
|
3-[3,5-Dimethyl-1-(Phenylmethyl)Pyrazol-4-Yl]Propionic acid
|
C15H17N2O2
|
381680-28-0
|
3-Ethoxy-4-[(2-Methylbenzyl)Oxy]Benzaldehyde
|
C17H18O3
|
381684-96-4
|
5-(4-Fluorophenyl)-3-pyridinecarboxaldehyde
|
C12H8FNO
|
381697-36-5
|
3-(3,5-Dimethyl-1-Phenyl-1H-Pyrazol-4-Yl)-Propionic Acid
|
C14H15N2O2
|
381716-33-2
|
D-Galactose 1-[2-(2-Azidoethoxy)Ethoxyethyl]-2,3,4,6-Tetra-O-Acetate
|
C20H31N3O11
|
381716-41-2
|
DL-2-Hydroxy-n-Butyric Acid Lithium Salt
|
C4H7LiO3
|
381721-55-7
|
1-(2-Imidazol-1-Yl-Ethyl)-Piperazine
|
C9H16N4
|
381721-56-8
|
1-[2-(1H-Pyrazol-1-Yl)Ethyl]-Piperazine
|
|
381723-16-6
|
2-Ethynyl-1,3-Difluorobenzene
|
C8H4F2
|
381725-44-6
|
(6-Methoxy-3-Pyridinyl)(2-Pyridinyl)Methanone
|
C12H10N2O2
|
381725-49-1
|
6'-Methoxy-2,3'-bipyridine;2-Methoxy-5-(pyridin-2-yl)pyridine
|
C11H10N2O
|
381725-50-4
|
1'-Phenyl-(2,3'-bipyridin)-6'(1'H)-one
|
C16H12N2O
|
382141-68-6
|
1-(3-Methoxyphenoxy)-2-Propanol
|
C10H14O3
|
382146-66-9
|
Bacopaside II
|
C47H76O18
|
382148-47-2
|
Bacopaside I
|
C46H74O20S
|
382150-50-7
|
1-Hexyl-3-methylimidazolium bis(trifluoromethanesulfonyl)amide;1-Hexyl-3-methylimidazolium bis((trifluoromethyl)sulfonyl)amide; 1-Hexyl-3-methylimidazolium bis((trifluoromethyl)sulfonyl)imide; 1-Methyl-3-hexylimidazolium bis(trifluoromethylsulfonyl)imide; HMI-FSI
|
C10H19N2.C2F6NO4S2
|
382167-57-9
|
2-Methyl-5-Phenyl-3-Furonitrile
|
C12H9NO
|
382180-17-8
|
Pyroxamide;N-Hydroxy-N'-3-pyridinyloctanediamide
|
C13H19N3O3
|
382597-97-9
|
4-([1,3,4]Thiadiazol-2-Ylcarbamoyl)-Butyric Acid
|
C7H8N3O3S
|
382631-42-7
|
1,2,9-Nonanetriol
|
C9H20O3
|
382631-43-8
|
1,2,8-Octanetriol
|
C8H18O3
|
383126-80-5
|
4-(2-Ethylphenoxy)Aniline
|
C14H15NO
|
383127-11-5
|
2-(2,4-Dimethoxyphenyl)pyrrolidine
|
C12H17NO2
|
383127-22-8
|
2-(4-Bromophenyl)pyrrolidine
|
C10H12BrN
|
383127-25-1
|
2-Furan-3-ylpyrrolidine
|
C8H11NO
|
383127-28-4
|
2-(4-Ethoxyphenyl)pyrrolidine
|
C12H17NO
|
383127-39-7
|
2-(2,6-Dichlorophenyl)pyrrolidine
|
C10H11Cl2N
|
383127-41-1
|
2-(2,3-Dimethoxyphenyl)pyrrolidine
|
C12H17NO2
|
383127-42-2
|
2-(2,6-Dimethoxyphenyl)pyrrolidine
|
C12H17NO2
|
383127-44-4
|
2-(3,5-Dimethylphenyl)pyrrolidine
|
C12H17N
|
383127-57-9
|
2-(2-Pyrrolidinyl)pyrazine;2-Pyrrolidinylpyrazine
|
C8H11N3
|
383127-68-2
|
2-(4-Bromobenzyl)pyrrolidine
|
C11H14BrN
|
383127-69-3
|
2-(2,4-Dichlorophenyl)pyrrolidine
|
C10H11Cl2N
|